Search results
AstraZeneca to withdraw COVID vaccine globally as demand dips
Reuters· 7 days ago, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 16 hours agoThey are also testing the cancer vaccine in patients with lung cancer. So, is Moderna stock...nearly...
What to Know About the FLiRT COVID-19 Variants
AARP· 6 days agoWith national levels of respiratory illness declining and warmer weather on the horizon, COVID-19 may no longer be top of mind. Right now, all eyes in...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 2 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
NBC Chicago· 7 days agoPharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as...
Britain refuses to sign global vaccine treaty that would force it to give away fifth of jabs
The Telegraph via Yahoo News· 6 days agoBritain is refusing to sign the World Health Organisation’s pandemic treaty while it insists the UK...
Nursing homes cite COVID-19 immunity laws in wrongful death suits
Modern Healthcare· 16 hours agoIn early 2020, with reports of COVID-19 outbreaks making dire headlines, Trever Schapers worried about her father’s safety in a nursing home in Queens.
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
One of the most shorted stocks on the market just leapt 99%, putting a ‘rib-crunching’ squeeze on...
Fortune· 4 days agoShares of the vaccine maker soared 99% Friday, after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...